论文部分内容阅读
目的观察KCNQ2/3通道电流特征及M1受体激活对该电流的调节作用.方法以CHO细胞作为表达体系,用脂质体共转染KCNQ2、KCNQ3钾离子通道及毒蕈碱型M1受体.全细胞膜片钳方法,观察KCNQ2/3电流特征,药理学阻断剂的作用及M1受体激活对电流的调节.结果KC-NQ2/3电流呈现慢激活、低阈值、非失活、电压依赖性的外向钾离子电流特点,其激活电压的阈值在-60 mV,半数激活电压值(-26.8±1.2)mV,其去活曲线可用双指数方程拟合,fτast约101 m s;sτlow约为309 m s.该电流对4-AP,Ba2+,TEA不敏感,L inop ird ine抑制KCNQ2/3电流IC50为(6.5±0.83)μmol.L-1.乙酰胆碱激活M1受体后会可逆性地抑制KCNQ2/3电流,其抑制的IC50为(0.7±0.05)μmol.L-1.结论KCNQ2/3通道作为神经细胞M通道的分子基础,其电流特征与M电流一致,L inop ird ine对其有较强阻断作用,神经递质乙酰胆碱通过激活M1受体明显抑制该通道电流.研究KCNQ2/3通道电流特征及受体调节规律,对于理解与中枢兴奋性有关的疾病如:惊厥、癫痫、阿尔采末病等发生机制有重要指导意义.“,”Aim To study the characteristics of KCNQ2/3 potassium channel expressed in CHO cells and its modulation by M1 receptor.Methods KCNQ2 and KCNQ3 potassium channels and M1 receptor were co-expressed in CHO cells.Whole cell patch-clamp techniques was used to observe the characteristics of KCNQ2/3 current,its modulation by the M1 receptor,and the effects of the common potassium channel blockers.Results KCNQ2/3 current recorded in CHO cells was a slow-activation low-threshold non-inactivating,voltage-dependent outward potassium current.KCNQ2/3 current was elicited at about-60 mV,V1/2(-26.8±1.2) mV and the deactivation current fitted two exponential function,with τfast of 101ms and τslow of 309 ms.The channel was not sensitive to common pharmacological blockers such as 4-AP,Ba2+ and TEA,but was inhibited significantly by linopirdine,with a IC50 of(6.5±0.83) μmol·L-1.Acetylcholine suppressed the KCNQ2/3 current reversibly via M1 receptor,with a IC50 of(0.7±0.05) μmol·L-1.Conclusion KCNQ2 and KCNQ3 channels are the molecular basis of M-current observed in neuronal cells.KCNQ2/Q3 current expressed in CHO cells has similar characteristics as that seen in neuronal M-current.Linopirdine is a powerful blocker of KCNQ2/3 channel and acetylcholine inhibits the current by muscarinic M1 receptor.This experiment has laid a solid basis for further study of M-current and KCNQ2/3 current,and is important for the study of neurological diseases relating to alteration of M-current,such as convulsion,epilepsy and Alzheimers disease.